The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Smoking and Prostate Cancer Survival and Recurrence
Open accessAbstract
CONTEXT: Studies of smoking in relation to prostate cancer mortality or recurrence in prostate cancer patients are limited, with few prostate cancer-specific outcomes. OBJECTIVE: To assess the relation of cigarette smoking and smoking cessation with overall, prostate cancer-specific, and cardiovascular disease (CVD) mortality and biochemical recurrence among men with prostate cancer. DESIGN, SETTING, AND PARTICIPANTS: Prospective observational study of 5366 men diagnosed with prostate cancer between 1986 and 2006 in the Health Professionals Follow-Up Study. MAIN OUTCOME MEASURES: Hazard ratios (HRs) for overall, prostate cancer-specific, and CVD mortality, and biochemical recurrence, defined by an increase in prostate-specific antigen (PSA) levels. RESULTS: There were 1630 deaths, 524 (32%) due to prostate cancer and 416 (26%) to CVD, and 878 biochemical recurrences. Absolute crude rates for prostate cancer-specific death for never vs current smokers were 9.6 vs 15.3 per 1000 person-years; for all-cause mortality, the corresponding rates were 27.3 and 53.0 per 1000 person-years. In multivariable analysis, current vs never smokers had an increased risk of prostate cancer mortality (HR, 1.61; 95% confidence interval [CI], 1.11-2.32), as did current smokers with clinical stage T1 through T3 (HR, 1.80; 95% CI, 1.04-3.12). Current smokers also had increased risk of biochemical recurrence (HR, 1.61; 95% CI, 1.16-2.22), total mortality (HR, 2.28; 95% CI, 1.87-2.80), and CVD mortality (HR, 2.13; 95% CI, 1.39-3.26). After adjusting for clinical stage and grade (likely intermediates of the relation of smoking with prostate cancer recurrence and survival), current smokers had increased risk of prostate cancer mortality (HR, 1.38; 95% CI, 0.94-2.03), as did current smokers with clinical stage T1 through T3 (HR, 1.41; 95% CI, 0.80-2.49); they also had an increased risk of biochemical recurrence (HR, 1.47; 95% CI, 1.06-2.04). Greater number of pack-years was associated with significantly increased risk of prostate cancer mortality but not biochemical recurrence. Current smokers of 40 or more pack-years vs never smokers had increased prostate cancer mortality (HR, 1.82; 95% CI, 1.03-3.20) and biochemical recurrence (HR, 1.48; 95% CI, 0.88-2.48). Compared with current smokers, those who had quit smoking for 10 or more years (HR, 0.60; 95% CI, 0.42-0.87) or who have quit for less than 10 years but smoked less than 20 pack-years (HR, 0.64; 95% CI, 0.28-1.45) had prostate cancer mortality risks similar to never smokers (HR, 0.61; 95% CI, 0.42-0.88). CONCLUSIONS: Smoking at the time of prostate cancer diagnosis is associated with increased overall and CVD mortality and prostate cancer-specific mortality and recurrence. Men who have quit for at least 10 years have prostate cancer-specific mortality risks similar to those who have never smoked.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roach, M., Hanks, G., Thames, H., Schellhammer, P., Shipley, W. U., Sokol, G. H., & Sandler, H. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.04.029 · Cited by 2,749
The Health Consequences of Smoking: A Report of the Surgeon General
Office on Smoking (2004) · Cited by 2,414
Heinonen, O. P., Koss, L., Albanes, D., Taylor, P. R., Hartman, A. M., Edwards, B. K., Virtamo, J., Huttunen, J. K., Haapakoski, J., Malila, N., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.6.440 · Cited by 918
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis
Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., Tsao, P. S., Johnson, F. L., & Cooke, J. P. (2001) · Nature Medicine · doi:10.1038/89961 · Cited by 800
Test of the National Death Index and Equifax Nationwide Death Search
Rich-Edwards, J. W., Corsano, K. A., & Stampfer, M. J. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117191 · Cited by 530
Giovannucci, E., Liu, Y., Platz, E. A., Stampfer, M. J., & Willett, W. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22788 · Cited by 522
Ma, J., Li, H., Giovannucci, E., Mucci, L., Qiu, W., Nguyen, P. L., Gaziano, J. M., Pollak, M., & Stampfer, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70235-3 · Cited by 421
Cigarette smoking: cancer risks, carcinogens, and mechanisms
Hecht, S. S. (2006) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-006-0111-z · Cited by 256
Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro
Villablanca, A. C. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.84.6.2089 · Cited by 228
Chan, J. M., Stampfer, M. J., Ma, J., Rimm, E. B., Willett, W. C., & Giovannucci, E. L. (1999) · PubMed · Cited by 193
Shiels, M. S., Rohrmann, S., Menke, A., Selvin, E., Crespo, C. J., Rifai, N., Dobs, A., Feinleib, M., Guallar, E., & Platz, E. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9318-y · Cited by 166
Smoking and risk of total and fatal prostate cancer in United States health professionals.
Giovannucci, E. L., Rimm, E. B., Ascherio, A., Colditz, G. A., Spiegelman, D. L., Stampfer, M. J., & Willett, W. C. (1999) · PubMed · Cited by 158
Wilson, K. M., Kasperzyk, J. L., Rider, J. R., Kenfield, S. A., van Dam, R. M., Stampfer, M. J., Giovannucci, E. L., & Mucci, L. A. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr151 · Cited by 156
Self-citationChan, J. M., Holick, C. N., Leitzmann, M. F., Rimm, E. B., Willett, W. C., Stampfer, M. J., & Giovannucci, E. L. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-0413-4 · Cited by 155
Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men
Allen, N. E., Appleby, P. N., Davey, G. K., & Key, T. J. (2002) · Cancer Causes & Control · doi:10.1023/a:1015238102830 · Cited by 153
Case-control study of toenail cadmium and prostate cancer risk in Italy
Vinceti, M., Venturelli, M., Sighinolfi, M. C., Trerotoli, P., Bonvicini, F., Ferrari, A., Bianchi, G. P., Serio, G., Bergomi, M., & Vivoli, G. (2006) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2006.11.005 · Cited by 153
Waalkes, M. P., & Rehm, S. (1994) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399409531920 · Cited by 147
Smoking history and cancer patient survival: a hospital cancer registry study.
Yu, G. P., Ostroff, J. S., Zhang, Z., Tang, J., & Schantz, S. P. (1997) · PubMed · Cited by 120
Comparison of biochemical failure definitions for permanent prostate brachytherapy
Kuban, D. A., Levy, L. B., Potters, L., BEYER, D. C., Blasko, J. C., Moran, B. J., Ciezki, J. P., Zietman, A. L., Zeléfsky, M. J., Pisansky, T. M., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.03.027 · Cited by 118
Smoking and aggressive prostate cancer: a review of the epidemiologic evidence
Zu, K., & Giovannucci, E. L. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9387-y · Cited by 114
Endogenous testosterone levels and smoking in men. The fifth Tromsø study
Svartberg, J., & Jorde, R. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2006.00720.x · Cited by 111
Cigarette Smoking and Prostate Cancer Recurrence After Prostatectomy
Joshu, C. E., Mondul, A. M., Meinhold, C. L., Humphreys, E. B., Han, M., Walsh, P. C., & Platz, E. A. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr124 · Cited by 91
THE EFFECT OF SMOKING ON OUTCOME FOLLOWING EXTERNAL RADIATION FOR LOCALIZED PROSTATE CANCER
Pickles, T., LIU, M., Berthelet, E., Kim‐Sing, C., Kwan, W., Tyldesley, S. K., & INITIATIVE, O. B. O. T. P. C. O. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000118292.25214.a4 · Cited by 81
Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men
Gong, Z., Agalliu, I., Lin, D. W., Stanford, J. L., & Kristal, A. R. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9066-9 · Cited by 73
A Worse Prognosis for Smokers with Prostate Cancer
Daniell, H. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67253-7 · Cited by 72
Pantarotto, J. R., Malone, S. C., Dahrouge, S., Gallant, V., & Eapen, L. J. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06656.x · Cited by 69
Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma
Enokida, H., Shiina, H., Urakami, S., Terashima, M., Ogishima, T., Li, L., Kawahara, M., Nakagawa, M., Kane, C. J., Carroll, P. R., et al. (2005) · Cancer · doi:10.1002/cncr.21577 · Cited by 68
Cancer screening behaviors among smokers and non-smokers
Byrne, M. M., Davila, E. P., Zhao, W., Parker, D. F., Hooper, M. W., Caban-Martinez, A. J., Dietz, N. A., Huang, Y., Messiah, A., & Lee, D. J. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.06.017 · Cited by 65
Oefelein, M. G., & Resnick, M. I. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000125123.46733.93 · Cited by 56
Benbrahim‐Tallaa, L., Liu, J., Webber, M. M., & Waalkes, M. P. (2006) · The Prostate · doi:10.1002/pros.20479 · Cited by 55
Tamimi, R., Mucci, L. A., Spanos, E., Lagiou, A., Benetou, V, & Trichopoulos, D. (2001) · European Journal of Cancer Prevention · doi:10.1097/00008469-200106000-00012 · Cited by 45
Clearing the smoke on nicotine and angiogenesis
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/89889 · Cited by 37
Handa, K. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06041-8 · Cited by 35
Moreira, D. M., Antonelli, J. A., Presti, J. C., Aronson, W. J., Terris, M. K., Kane, C. J., Amling, C. L., & Freedland, S. J. (2010) · Urology · doi:10.1016/j.urology.2010.01.066 · Cited by 31
Beeinflusst Rauchen das Überleben von Prostatakarzinompatienten?
Jäger, T., Eisenhardt, A., Rubben, H., & Lümmen, G. (2007) · Der Urologe · doi:10.1007/s00120-006-1252-y · Cited by 11
Cigarette Smoking and Prostate Cancer Recurrence After Prostatectomy
Kibel, A. S. (2012) · Yearbook of Urology · doi:10.1016/j.yuro.2011.12.004 · Cited by 7
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
Bergengren, O., Pekala, K. R., Matsoukas, K., Fainberg, J., Mungovan, S. F., Bratt, O., Bray, F., Brawley, O., Luckenbaugh, A. N., Mucci, L., et al. (2023) · European Urology · doi:10.1016/j.eururo.2023.04.021 · Cited by 848
Smoking and Mortality — Beyond Established Causes
Carter, B. D., Abnet, C. C., Feskanich, D., Freedman, N. D., Hartge, P., Lewis, C. E., Ockene, J. K., Prentice, R. L., Speizer, F. E., Thun, M. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1407211 · Cited by 809
The Epidemiology of Prostate Cancer
Pernar, C. H., Ebot, E. M., Wilson, K. M., & Mucci, L. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030361 · Cited by 773
Smoking at diagnosis and survival in cancer patients
Warren, G. W., Kasza, K. A., Reid, M. E., Cummings, K. M., & Marshall, J. R. (2013) · International Journal of Cancer · doi:10.1002/ijc.27617 · Cited by 265
Metadata
- Authors
- Kenfield, S. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-06-22
- Volume
- 305
- Issue
- 24
- Pages
- 2548
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2002395040
- Cited by
- 275
- References
- 36
- FWCI
- 22.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.